California Parents File Zofran Lawsuit Against GlaxoSmithKline

California Parents File Zofran Lawsuit Against GlaxoSmithKline

Sarah R. London and Paulina do Amaral of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announce that Paul Ramirez and Dulce A. Morga, residents of Los Angeles County, California, have filed a personal injury lawsuit against pharmaceutical giant GlaxoSmithKline LLC (“GSK”) for injuries leading to the death of their infant daughter, Baby Sarah Ramirez Morga, allegedly as a result of Ms. Morga being prescribed GSK’s drug ondansetron (brand name Zofran) while pregnant.

[Read more…]

Florida Parents File Suit to Hold GlaxoSmithKline Accountable for Injuries Suffered By Their Son and Warn Pregnant Mothers of the Link Between Zofran and Birth Defects

Zofran birth defect lawsuits

Sarah R. London and Paulina do Amaral of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announce that Robin and Stanley Zgurski, residents of Florida, have filed a personal injury lawsuit against pharmaceutical giant GlaxoSmithKline LLC (“GSK”) for the injuries suffered by their son allegedly as a result of Ms. Zgurski being prescribed GSK’s drug ondansetron (brand name Zofran) while pregnant. [Read more…]

Sarah London Discusses Zofran Anti-Nausea Medication Birth Defect Injury Lawsuits

Sarah London Discusses Dangerous Birth Defects from Zofran (ondansetron) Use

Parents charge that Zofran (generic name ondansetron) is a dangerous and defective drug because its use by pregnant women can lead to serious birth defects. Zofran was approved by the FDA in 1991 to treat extreme nausea from chemotherapy and later expanded for use as a treatment for serious surgical nausea. Lawsuits allege that the drug has been marketed off-label by GlaxoSmithKline to obstetricians and gynecologists to prescribe to their pregnant patients to control the pregnancy nausea commonly referred to as “morning sickness.”

[Read more…]

April 2015 Zofran Injuries and Lawsuits Update

April 2015 Zofran Injuries and Lawsuits Update

Zofran has become a widely popular morning sickness treatment. Physician expectations were that the anti-nausea drug would benefit the patient, but GlaxoSmithKline, the manufacturer of Zofran, allegedly provided little information on the drug’s effect on unborn children. In numerous lawsuits, parents charge that GlaxoSmithKline failed to warn about an association between Zofran and certain very specific birth defects such as cleft palate and heart defects.

[Read more…]